Biography

A Founder at the Intersection of Pharma & Regulation

Vishal Om Prakash Chakravarty is a pharmaceutical entrepreneur based across the United Kingdom and Vadodara, Gujarat, India. As Founder and Chief Executive Officer of NovaPharm Healthcare Ltd — registered in England and Wales (Companies House No. 16716501) — he has built an organisation dedicated to ensuring pharmaceutical products navigate the UK and European regulatory landscape with full compliance and commercial precision.

His work spans the complete pharmaceutical market access lifecycle: obtaining MHRA Parallel Import Product Licences (PLPI), qualifying EU-GMP certified manufacturers, managing GDP-compliant supply chains, and engaging NICE health technology assessment frameworks for NHS reimbursement. With deep expertise in post-Brexit regulatory divergence between the MHRA and the EMA, Vishal provides a reliable bridge between international pharmaceutical manufacturers and the British healthcare market.

“Regulatory compliance is not a constraint — it is the foundation upon which patient safety and commercial success are both built.”

— Vishal Chakravarty

Beyond regulatory operations, Vishal is an active thought leader — contributing to Yakuji Nippo (薬事日報), Japan's foremost pharmaceutical industry daily — and writing long-form essays on pharmaceutical strategy, regulatory innovation, and market dynamics. He also leads Novapharm Innovation Technology, the India-based R&D and services arm of the NovaPharm group, providing pharmaceutical services across MHRA, EMA, and Health Canada regulatory environments.

Areas of Expertise

Core Competencies

Grounded in practical application across the full pharmaceutical value chain — from regulatory filing through to commercial market access.

MHRA PLPI Licensing

End-to-end management of Parallel Import Product Licence applications, marketing authorisations, and post-approval obligations within the UK's post-Brexit regulatory framework.

EU-GMP Supplier Qualification

Systematic qualification and auditing of EU-GMP certified manufacturers, ensuring batch documentation integrity and supply chain traceability to MHRA standards.

Parallel Import Logistics

Operational expertise in cross-border pharmaceutical parallel importation — covering re-labelling, language compliance, pharmacovigilance, and UK customs obligations.

NICE HTA & NHS Formulary

Strategic engagement with NICE health technology assessment processes and NHS formulary access — particularly within oncology and high-cost medicine procurement.

Post-Brexit Regulatory Divergence

Expert navigation of diverging MHRA and EMA regulatory pathways following Brexit — advising on registration strategy, product variations, and compliance obligations in both markets.

GDP-Compliant Distribution

Design and management of GDP-compliant pharmaceutical distribution networks, covering cold chain, temperature monitoring, qualified person oversight, and audit readiness.

Registry & Credentials

Verifiable & Public

All credentials, company registrations, and professional contributions are publicly verifiable through official registries and established platforms.

Companies House Registration

NovaPharm Healthcare Ltd is officially registered in England and Wales. Company No. 16716501. Vishal's directorship is publicly verifiable through the UK Government's official company registry.

Verify on Companies House ↗

Wikidata Entity

Vishal Chakravarty has a structured knowledge entity on Wikidata at Q130325741, enabling machine-readable identity signals that support Google Knowledge Graph and Knowledge Panel appearance.

View Wikidata Q130325741 ↗

Yakuji Nippo Contributor

Active contributor to Yakuji Nippo (薬事日報) — Japan's foremost pharmaceutical industry publication, providing expert commentary on UK and EU pharmaceutical regulatory developments.

View contributor profile ↗

Crunchbase & Wikipedia

Professional profile documented across Wikipedia and Crunchbase — providing independent, third-party verification of entrepreneurial activity and business credentials.

View Crunchbase profile ↗

Thought Leadership

Published Work & Writing

Long-form essays and published analysis on pharmaceutical strategy, regulatory innovation, and the business of building in regulated industries.

Regulatory Strategy

Regulated Industries: Building Where Others Won't

A strategic analysis of why high-barrier regulated industries create durable competitive advantages — and how to enter them with the right regulatory and commercial infrastructure.

Read essay →
MHRA Compliance

What Parallel Import Actually Means

A practitioner's breakdown of the PLPI application process — timelines, pharmacovigilance obligations, re-labelling requirements, and the commercial opportunity within the UK parallel import market.

Read essay →
Entrepreneurship

How to Win When the Odds Are Against You

A strategic framework for founders operating in complex, high-resistance environments — drawing on the realities of building NovaPharm Healthcare in a post-Brexit regulatory landscape.

Read essay →
Career & Personal

Why I Left Swiggy

A candid reflection on leaving a high-growth tech company to build in pharmaceutical regulation — and why the complexity of healthcare was more compelling than the simplicity of scale.

Read essay →
View all publications →

Contact

Connect

Connect to discuss pharmaceutical regulatory strategy, market access, investment & partnership opportunities, or media enquiries.